Medindia

X

FDA Probes Safety of New Class of Diabetic Drugs

by Kathy Jones on  March 16, 2013 at 8:38 PM Diabetes News   - G J E 4
The US Food and Drug Administration revealed that it will be conducting an investigation to check whether a newly approved class of type II diabetes drugs increased the risk of pancreatitis and the development of precancerous changes in the pancreas.
 FDA Probes Safety of New Class of Diabetic Drugs
FDA Probes Safety of New Class of Diabetic Drugs
Advertisement

The class of drugs is known as incretin mimetics and some of the drugs currently being investigated by the FDA include Merck's Januvia and Janumet, Danish-based Novo Nordisk's Victoza and Bristol-Myers Squibb's Byetta and Bydureon.

Advertisement
The agency revealed that pancreas tissue samples taken from a small number of patients displayed inflammation and cellular changes often seen before cancer develops. However it was quick to clarify that the investigation did not mean it believed the drugs could lead to pancreatic cancer. "FDA has not concluded these drugs may cause or contribute to the development of pancreatic cancer. At this time, patients should continue to take their medicine as directed", an agency statement said.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like